Event Details

This document is page 80 of a financial research report produced by Cowen, dated February 25, 2019, analyzing the regulatory landscape for medical cannabis and CBD in Europe. It details the European Parliament's non-binding resolution to harmonize cannabis policies, compares THC limits between the EU (0.2%) and North America (0.3%), and discusses the classification of CBD within the 'Novel Food Catalogue.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.